WVE
Wave Life Sciences Ltd
4.00$
+0.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.8% | +111.4% | +32.0% | +174.9% | +159.0% | +64.9% | +8.5% | -1.5% | +2.8% | -9.0% | -5.9% | +2.2% | |
| – | – | +28,642.9% | +70.2% | +77.3% | +28.4% | +25.1% | -26.7% | +14.8% | +4.8% | -43.0% | +34.2% | +90.0% | |
| – | – | +4,626.1% | +47.3% | +159.9% | -6.0% | +24.7% | -26.7% | +14.8% | +4.9% | – | – | – | |
| – | – | +349.1% | +739.3% | -101.8% | – | -122.8% | – | -27.3% | -4.1% | +183.9% | -497.4% | – | |
| – | +1,155.3% | +214.7% | +199.8% | +239.3% | -47.4% | -60.6% | -65.8% | -58.1% | +143.0% | -18.1% | -15.9% | -23.5% | |
| – | +446.8% | +1,031.9% | +180.6% | +131.5% | -47.4% | -60.6% | -65.8% | -58.1% | +124.1% | -11.2% | -15.9% | -23.5% | |
| – | – | – | -73.5% | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | +3,035.8% | -82.8% | +212.1% | -31.1% | +152.5% | -42.4% | -41.0% | +18.4% | – | – | – | |
| – | – | +0.0% | -50.8% | +0.0% | -74.2% | – | – | – | – | – | – | – | |
| – | +53.0% | +3,025.0% | -83.4% | +224.1% | -31.0% | +152.6% | -6.0% | -63.9% | +20.3% | +97.3% | +91.6% | +92.3% | |
| – | +915.0% | +26,200.8% | -106.8% | – | – | -185.5% | – | -190.9% | – | – | -9.0% | +194.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.